Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san francisco blog main
boston blog main
boston top stories
cancer
clinical trials
fda
loxo oncology
national top stories
san diego blog main
san diego top stories
startups
acute myeloid leukemia
adverum biotechnologies
ambit biosciences
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
athena countouriotis
avrobio
black diamond therapeutics
bladder cancer
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brett zbar
brexanolone
bristol-myers squibb
camp4 therapeutics
cancer drugs
cancer immunotherapy
cormorant asset management
crispr therapeutics
crispr-cas9
daiichi sankyo
deals
deciphera pharmaceuticals
denali therapeutics
What
biotech
3
×
cancer
3
×
drug
3
×
new
therapeutics
ahead
ambien
american
annual
asco
athena
attendees
attention
black
camp’s
cash
ceo
chicago
chief
city
clinic
clinical
combinations
community’s
companies
countouriotis
days
diamond
eluded
expanding
financing
focus
gets
home
hopes
ipo
key
kicks
lead
leading
Language
unset
Current search:
biotech
×
cancer
×
drug
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
